20110811
 Corporate News: Pfizer Tells U.S. About Payments   By Loftus, Peter, The Wall Street Journal,  Aug 12, 2011  U.S.-based multinational drug and medical-device makers have been among the targets of enforcement because they promote their products to doctors employed by national health systems outside the U.S. Earlier this year, Johnson & Johnson agreed to pay nearly $80 million to resolve allegations that it paid bribes to doctors in three European countries, as well as kickbacks to Iraq to illegally obtain business under former leader Saddam Hussein.   
